Search clinical trials for: SP-333

Total 937 results

Sichuan Clover Biopharmaceuticals, Inc.

Terminated

A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

China
Karyopharm Therapeutics Inc

Withdrawn

Efficacy & Safety Study of KPT-330 in Erythropoietin-Refractory Lower-Risk Myelodysplastic Syndrome Patients (SIER)

Myelodysplastic Syndrome
Clover Biopharmaceuticals AUS Pty Ltd

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions

Malignant Pleural Effusions

Australia
Solvay Pharmaceuticals

Completed

Study to Investigate ADME of 14C Labeled SLV334 After an i.v. Infusion

Pharmacology, Clinical

Netherlands
Benha University

Completed

Interleukin 33 in Juvenile Idiopathic Arthritis Patients

Juvenile Idiopathic Arthritis

Egypt
Bhavana Bhatnagar
Karyopharm Therapeutics Inc

Completed

Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia

United States
University of Minnesota

Completed

Resistant Starch and Satiety

Healthy Adults

United States
Amgen

Not yet recruiting

A Study to Evaluate AMG 133 in Chinese Participants With Obesity or Overweight

Obesity
GWT-TUD GmbH
Miltenyi Biomedicine GmbH

Terminated

Immunoadsorption in Patients With Severe Systemic Sclerosis

Systemic Scleroderma

Germany
AbbVie

Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion

Immunoglobulin Light Chain (AL) Amyloidosis

Japan
Alpine Immune Sciences, Inc.

Recruiting

An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias (RUBY-4)

Immune Thrombocytopenia | Idiopathic Thrombocytopenic Purpura | Cold Agglutinin Disease | Warm Autoimmune Hemolytic Anemia

United States, Canada, Australia, Turkey, United Kingdom
Amgen

Completed

Study of AMG 133 Administered Subcutaneously in Healthy Japanese and Caucasian Participants

Healthy Participants

United States
AbbVie

Completed

A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy

Ulcerative Colitis (UC)

United States, Canada, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Spain, United Kingdom
Amgen

Completed

A Study of AMG 337 in Subjects With Advanced Solid Tumors

Cancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology Patients

United States
Chong Kun Dang Pharmaceutical

Completed

A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions

Type2Diabetes

Korea, Republic of
Sichuan Clover Biopharmaceuticals, Inc.

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Ascites

Malignant Ascites

China
Clover Biopharmaceuticals AUS Pty Ltd

Completed

Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Peritoneal Malignancies

Peritoneal Malignancies

Australia
GenMont Biotech Incorporation
National Science Council, Taiwan

Completed

Probiotics and Allergic Diseases (probiotics)

Asthma | Atopic Dermatitis

Taiwan
The University of Texas Health Science Center at...
Abfero Pharmaceuticals, Inc

Suspended

Safety of SP-420 in the Treatment of Transfusional Iron Overload

Iron Overload

United States
HTL-Strefa S.A.

Completed

The Characteristics of Different Personal Lancets on Blood Volume and Perceived Pain in Patients With Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1
Duke University
Abbott Medical Devices

Completed

Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT) (Devise-CRT)

Heart Failure | Cardiomyopathy

United States
Karyopharm Therapeutics Inc

Withdrawn

Study of Safety, Tolerability, and Pharmacokinetics of Topical Selinexor (KPT-330) Diabetic Foot Ulcer (DFU) Patients

Diabetic Foot Ulcers

New Zealand
Pfizer

Completed

ACTiF- Assessment of Closed Tibial Fractures

Tibial Fractures

United States, Australia, Canada, Spain, Turkey, Croatia, India, Bosnia and Herzegovina, Japan, Russian Federation, South Africa
Fundació Institut de Recerca de l'Hospital de la...

Terminated

Postoperative Bleeding Prevention in Massive Bone Tumour Resection (TRANEXTUM)

Blood Loss | Bone Tumour

Spain
University of Florida
Inventiva Pharma

Completed

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease (NAFLD) | Type 2 Diabetes (T2DM)

United States
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics Inc

Completed

Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
BeiGene

Terminated

Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors

Advanced Solid Tumors

Australia, Spain, New Zealand
Royan Institute

Completed

Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction

Myocardial Infarction

Iran, Islamic Republic of
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder

Major Depressive Disorder
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Recruiting

Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior

Behavior, Risk

United States
Avid Radiopharmaceuticals

Terminated

A Trial of 18F-AV-133 Positron Emission Tomography (PET)

Type 1 Diabetes | Type 2 Diabetes

United States
Avid Radiopharmaceuticals

Completed

A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders

Parkinson's Disease | Primary Parkinsonism | Lewy Body Parkinson's Disease

United States, Australia
SparX Biotech(Jiangsu) Co., Ltd.

Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303)

Solid Tumor | CRC | HNSCC | RCC

United States
Yonsei University

Unknown

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

Gastric Adenocarcinoma

Korea, Republic of
University of Copenhagen
The Danish Medical Research Council; Danisco

Completed

The Effect of Probiotics on Low-grade Inflammation, Microbiota and Risk Factors for Metabolic Syndrome in Obese Children

Inflammation | Obesity | Metabolic Syndrome

Denmark
Universiti Sains Malaysia
Xinxiang medical university

Not yet recruiting

The Efficacy of Probiotics for the Treatment of Alcohol Use Disorder Among Adult Males

Alcohol Use Disorder
Seagen Inc.

Terminated

Study of Vadastuximab Talirine (SGN-CD33A; 33A) in Combination With Azacitidine in Patients With Previously Untreated Higher Risk MDS

Myelodysplastic Syndrome

United States
Institute for Neurodegenerative Disorders
Molecular NeuroImaging

Terminated

Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-amyloid Protein Deposition

Alzheimer Disease

United States
Eli Lilly and Company

Completed

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

Solid Tumors

United States
Bial - Portela C S.A.

Completed

Relative Bioavailability and Bioequivalence of Opicapone

Parkinson Disease

United Kingdom
Pilar Jimenez Quevedo
Fundación Mutua Madrileña

Completed

Safety and Efficacy of Autologous Endothelial Progenitor Cell CD 133 for Therapeutic Angiogenesis (PROGENITOR)

Coronary Artery Disease | Refractory Angina

Spain
Uppsala University

Unknown

Bone Forming at Prosthetic Surfaces. Fingerprint2

Osteo Arthritis

Sweden
National Taiwan University Hospital

Recruiting

To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence

Esophageal Cancer

Taiwan
Takeda
Takeda Development Center Americas, Inc.

Recruiting

A Study of TAK-330 for Reversal of Direct Oral Factor Xa Inhibitor-induced Anticoagulation

Coagulation Disorder

United States, Spain, Belgium, France, Netherlands
Presidio Pharmaceuticals, Inc.

Completed

A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

Hepatitis C, Chronic

United Kingdom, Mauritius
Merck Sharp & Dohme LLC

Recruiting

A Study of MK-1484 as Monotherapy and in Combination With Pembrolizumab (MK-3475) In Advanced or Metastatic Solid Tumors (MK-1484-001)

Advanced or Metastatic Solid Tumors

United States, Canada, Israel, Netherlands
Sanofi

Completed

Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years

Influenza | Flu

China
Estudios Clínicos Latino América
Population Health Research Institute

Recruiting

The ECLA/PHRI Intervention in the Community Trial (EPIC)

Hypertension

Argentina
London School of Hygiene and Tropical Medicine
World Health Organization; Tropical Medicine Research Institute

Completed

Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in Sudan

Plasmodium Infections

Sudan
Zeria Pharmaceutical

Completed

The Effects of Z-338 in Subjects With and Without Functional Dyspepsia

Dyspepsia

Australia

Search clinical trials for: SP-333

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations